Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 40.46
-0.94 (-2.27%)
Sep 22, 2026, 4:08 PM HKT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 92.27 billion as of September 22, 2026. Its market cap has increased by 147.52% in one year.
Market Cap
92.27B
Enterprise Value
88.65B
Revenue
6.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
40.46
ChartMarket Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 92.27B, an increase of 4,268.79%. That is a compound annual growth rate of 42.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 92.27B | 239.79% |
| Dec 31, 2025 | 27.15B | 28.72% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 206.62B |
| Innovent Biologics | 168.17B |
| Sichuan Kelun-Biotech Biopharmaceutical | 110.33B |
| Sino Biopharmaceutical | 97.42B |
| Akeso | 83.36B |
| RemeGen | 63.08B |
| Biocytogen Pharmaceuticals (Beijing) | 59.62B |
| 3SBio | 39.25B |